2 European Projects Found
Searched on 125080 European Projects
FINISHED
DEferiprone Evaluation in Paediatrics (DEEP)
Start date: Jan 1, 2011, End date: Aug 31, 2016,
...py to remove harmful iron accumulation in the body. The use of deferoxamine, the first chelating agent only available for subcutaneous administration is limited due to toxicity and the lack of compliance, despite its satisfactory therapeutic effects. An oral iron chelating agent, deferiprone, was authorised in Europe in August 1999 and recommended for the treatment of iron overload in patients wi ...
Read Project
18
Partners Participants
FINISHED
Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE)
Start date: Nov 1, 2010, End date: Apr 30, 2016,
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children, affecting approximately 5% children in Europe. Methylphenidate (MPH) is the most-commonly prescribed medication for ADHD children; it is also increasingly used in ADHD adults. In 2007, the European Commission requested a referral to the Committee for Medicinal Products for Human Use ...
Read Project
